Annual Total Assets
$5.17 M
-$2.42 M-31.87%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual total assets is $5.17 million, with the most recent change of -$2.42 million (-31.87%) on December 1, 2023.
- During the last 3 years, RNAZ annual total assets has risen by +$4.11 million (+389.83%).
- RNAZ annual total assets is now -77.46% below its all-time high of $22.94 million, reached on December 31, 2021.
Performance
RNAZ Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$3.94 M
-$888.50 K-18.42%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly total assets is $3.94 million, with the most recent change of -$888.50 thousand (-18.42%) on September 1, 2024.
- Over the past year, RNAZ quarterly total assets has dropped by -$6.29 million (-61.52%).
- RNAZ quarterly total assets is now -84.48% below its all-time high of $25.36 million, reached on September 30, 2021.
Performance
RNAZ Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
RNAZ Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.9% | -61.5% |
| 3 y3 years | +389.8% | -84.5% |
| 5 y5 years | +2428.0% | - |
RNAZ Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -77.5% | at low | -82.8% | at low |
| 5 y | 5-year | -77.5% | +2428.0% | -84.5% | +279.1% |
| alltime | all time | -77.5% | +2428.0% | -84.5% | +279.1% |
TransCode Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.94 M(-18.4%) |
| Jun 2024 | - | $4.82 M(-33.8%) |
| Mar 2024 | - | $7.29 M(+41.0%) |
| Dec 2023 | $5.17 M(-31.9%) | $5.17 M(-49.5%) |
| Sep 2023 | - | $10.23 M(+73.9%) |
| Jun 2023 | - | $5.88 M(+5.2%) |
| Mar 2023 | - | $5.59 M(-26.3%) |
| Dec 2022 | $7.59 M | $7.59 M(-36.8%) |
| Sep 2022 | - | $12.02 M(-15.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $14.16 M(-24.9%) |
| Mar 2022 | - | $18.85 M(-17.8%) |
| Dec 2021 | $22.94 M(+2073.4%) | $22.94 M(-9.5%) |
| Sep 2021 | - | $25.36 M(+1565.9%) |
| Jun 2021 | - | $1.52 M(+46.6%) |
| Mar 2021 | - | $1.04 M(-1.6%) |
| Dec 2020 | $1.06 M(+416.1%) | - |
| Dec 2020 | - | $1.06 M |
| Dec 2019 | $204.50 K | - |
FAQ
- What is TransCode Therapeutics annual total assets?
- What is the all time high annual total assets for TransCode Therapeutics?
- What is TransCode Therapeutics annual total assets year-on-year change?
- What is TransCode Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly total assets year-on-year change?
What is TransCode Therapeutics annual total assets?
The current annual total assets of RNAZ is $5.17 M
What is the all time high annual total assets for TransCode Therapeutics?
TransCode Therapeutics all-time high annual total assets is $22.94 M
What is TransCode Therapeutics annual total assets year-on-year change?
Over the past year, RNAZ annual total assets has changed by -$2.42 M (-31.87%)
What is TransCode Therapeutics quarterly total assets?
The current quarterly total assets of RNAZ is $3.94 M
What is the all time high quarterly total assets for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly total assets is $25.36 M
What is TransCode Therapeutics quarterly total assets year-on-year change?
Over the past year, RNAZ quarterly total assets has changed by -$6.29 M (-61.52%)